loader image

GuficolPlus 1MIU

Therapeutic Category:

Description

Colistimethate is a powerful polymyxin antibiotic used to treat multidrug-resistant Gram-negative bacterial infections, including Pseudomonas aeruginosa and Acinetobacter baumannii. Administered intravenously or via inhalation, it’s vital in critical care settings for severe respiratory, urinary, bloodstream, and intra-abdominal infections unresponsive to other antibiotics.

Additional information

Pack Size

1*1

Form

Vial

Manufacturer

Guffic CritiCare

Storage Conditions

Ambient Temperature

Shelf Life

2 years

Delivery Process

Product information is meant for


Wholesalers Distributors Patients Hospitals Pharmacies Government Tenders Importers CROs Clinics Doctors Generic Drugs Branded Drugs Institutional Buyers Comparator Sourcing Product Registration

Disclaimer

  • We do not offer medical advice. Please consult a registered medical practitioner before purchasing.
  • All content and product information on this website is for informational purposes only.
  • Buyers are solely responsible for ensuring patent compliance in their respective countries.
  • Trademarks are used under the provisions of the Trade Marks Act, 1999, Sections 30 and 30(1), permitting fair use.
  • All products are sold in accordance with the Drugs and Cosmetics Act, 1940, as passed by the Parliament of India.

Disclaimer

Trade Marks displayed in compliance with provisions of: provisions Trademark Act, 1999 u/s 30 and 30 (1) of “Fair use”

GNH India is WHO GDP and ISO 9001 2015 Certified Pharmaceutical Wholesaler/ Supplier/ Exporters/ Importer from India of PANTIN-D CAP – Domperidone+ Pantoprazole which is also known as PANTIN and Manufactured by Hetro pharmaceutical. It is available in strength of (30mg) + (40mg) per ml.

PANTIN-D CAP – Domperidone+ Pantoprazole is supplied for Tenders/ Emergency imports/ Un – licensed, Specials, Orphan drug/ Name patient line/ RLD supplies/ Reference listed drugs/ Comparator Drug/ Bio-Similar/ Innovator samples For Clinical trials.

Read more from reference website

Add to quote

DISCLAIMER